STOCK Prnptm1Cwe Tg(Prnp*)CDah/Cnrm

Status

Available to order

EMMA IDEM:06142
International strain nameSTOCK Prnptm1Cwe Tg(Prnp*)CDah/Cnrm
Alternative nameTg(PG14-C)/Prnp0/0
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolPrnptm1Cwe, Tg(Prnp*)CDah
Gene/Transgene symbolPrnp, Tg(Prnp*)CDah

Information from provider

ProviderRoberto Chiesa
Provider affiliationNeuroscience, Istituto di Ricerche Farmacologiche Mario Negri
Additional ownerDavid A. Harris, Washington University in St. Louis, St. Louis MO, USA (now Professor and Chair Department of Biochemistry, Boston University School of Medicine, Boston MA, USA)
Genetic informationTransgenic mice expressing the mouse homolog (PG14) of a 72-amino acid (nine-octapeptide) insertion in the prion protein gene linked to an inherited prion disease.
Phenotypic informationThis mouse line expresses PG14 PrP at low levels (approximately 0.3 fold the endogenous PrP level) and does not develop a neurological illness.
Breeding historyThe transgenic (C57BL/6J x CBA) founder was backcrossed with Prnp0/0 mice (EM:00158) for two generations to obtain hemizygous transgenic mice with the disrupted Prnp gene. Tg(PG14-C+/-)/Prnp0/0 were intercrossed to obtain Tg(PG14-C+/+)/Prnp0/0 mice. The homozygous line is maintained inbred.
References
  • Neurological illness in transgenic mice expressing a prion protein with an insertional mutation.;Chiesa R, Piccardo P, Ghetti B, Harris D A, ;1998;Neuron;21;1339-51; 9883727
  • Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation.;Chiesa R, Drisaldi B, Quaglio E, Migheli A, Piccardo P, Ghetti B, Harris D A, ;2000;Proceedings of the National Academy of Sciences of the United States of America;97;5574-9; 10805813
  • Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.;Chiesa R, Pestronk A, Schmidt R E, Tourtellotte W G, Ghetti B, Piccardo P, Harris D A, ;2001;Neurobiology of disease;8;279-88; 11300723
  • Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease.;Chiesa Roberto, Piccardo Pedro, Dossena Sara, Nowoslawski Lisa, Roth Kevin A, Ghetti Bernardino, Harris David A, ;2005;Proceedings of the National Academy of Sciences of the United States of America;102;238-43; 15618403
  • Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities.;Chiesa Roberto, Piccardo Pedro, Biasini Emiliano, Ghetti Bernardino, Harris David A, ;2008;The Journal of neuroscience : the official journal of the Society for Neuroscience;28;13258-67; 19052217
  • Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model.;Dossena Sara, Imeri Luca, Mangieri Michela, Garofoli Anna, Ferrari Loris, Senatore Assunta, Restelli Elena, Balducci Claudia, Fiordaliso Fabio, Salio Monica, Bianchi Susanna, Fioriti Luana, Morbin Michela, Pincherle Alessandro, Marcon Gabriella, Villani Flavio, Carli Mirjana, Tagliavini Fabrizio, Forloni Gianluigi, Chiesa Roberto, ;2008;Neuron;60;598-609; 19038218
  • Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α(2)δ-1 Subunit.;Senatore Assunta, Colleoni Simona, Verderio Claudia, Restelli Elena, Morini Raffaella, Condliffe Steven B, Bertani Ilaria, Mantovani Susanna, Canovi Mara, Micotti Edoardo, Forloni Gianluigi, Dolphin Annette C, Matteoli Michela, Gobbi Marco, Chiesa Roberto, ;2012;Neuron;74;300-13; 22542184
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

MGI phenotypes (allele matching)
  • reduced long term potentiation / MGI
  • abnormal CNS synaptic transmission / MGI
  • abnormal inhibitory postsynaptic potential / MGI
  • abnormal inhibitory postsynaptic currents / MGI
  • behavior/neurological phenotype / MGI
  • decreased brain copper level / MGI
  • tremors / MGI
  • abnormal cerebellum morphology / MGI
  • decreased Purkinje cell number / MGI
MGI phenotypes (gene matching)
  • impaired fertilization / MGI
  • abnormal spleen morphology / MGI
  • tremors / MGI
  • abnormal cerebral cortex morphology / MGI
  • abnormal hippocampus morphology / MGI
  • abnormal olfactory bulb morphology / MGI
  • abnormal thalamus morphology / MGI
  • abnormal cerebellum morphology / MGI
  • Purkinje cell degeneration / MGI
  • decreased Purkinje cell number / MGI
  • abnormal cerebellar molecular layer / MGI
  • thin cerebellar molecular layer / MGI
  • abnormal retina morphology / MGI
  • ataxia / MGI
  • hypoactivity / MGI
  • impaired coordination / MGI
  • reduced long term potentiation / MGI
  • abnormal sleep pattern / MGI
  • abnormal body temperature homeostasis / MGI
  • male infertility / MGI
  • premature death / MGI
  • abnormal muscle physiology / MGI
  • abnormal brain morphology / MGI
  • no abnormal phenotype detected / MGI
  • gliosis / MGI
  • abnormal CNS synaptic transmission / MGI
  • neurodegeneration / MGI
  • spongiform encephalopathy / MGI
  • decreased vertical activity / MGI
  • abnormal inhibitory postsynaptic potential / MGI
  • abnormal inhibitory postsynaptic currents / MGI
  • no phenotypic analysis / MGI
  • increased neuron apoptosis / MGI
  • neuron degeneration / MGI
  • astrocytosis / MGI
  • abnormal voluntary movement / MGI
  • nervous system phenotype / MGI
  • abnormal nervous system morphology / MGI
  • impaired acrosome reaction / MGI
  • abnormal behavior / MGI
  • abnormal neuronal precursor proliferation / MGI
  • decreased susceptibility to prion infection / MGI
  • increased susceptibility to prion infection / MGI
  • behavior/neurological phenotype / MGI
  • immune system phenotype / MGI
  • teratozoospermia / MGI
  • brain vacuoles / MGI
  • abnormal brain white matter morphology / MGI
  • abnormal hippocampus CA1 region morphology / MGI
  • decreased neuron number / MGI
  • abnormal neuron differentiation / MGI
  • abnormal neuron proliferation / MGI
  • decreased brain copper level / MGI
  • enlarged brain ventricles / MGI
  • cerebellum atrophy / MGI
  • altered susceptibility to prion infection / MGI

Literature references

  • Neurological illness in transgenic mice expressing a prion protein with an insertional mutation.;Chiesa R, Piccardo P, Ghetti B, Harris D A, ;1998;Neuron;21;1339-51; 9883727
  • Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation.;Chiesa R, Drisaldi B, Quaglio E, Migheli A, Piccardo P, Ghetti B, Harris D A, ;2000;Proceedings of the National Academy of Sciences of the United States of America;97;5574-9; 10805813
  • Primary myopathy and accumulation of PrPSc-like molecules in peripheral tissues of transgenic mice expressing a prion protein insertional mutation.;Chiesa R, Pestronk A, Schmidt R E, Tourtellotte W G, Ghetti B, Piccardo P, Harris D A, ;2001;Neurobiology of disease;8;279-88; 11300723
  • Bax deletion prevents neuronal loss but not neurological symptoms in a transgenic model of inherited prion disease.;Chiesa Roberto, Piccardo Pedro, Dossena Sara, Nowoslawski Lisa, Roth Kevin A, Ghetti Bernardino, Harris David A, ;2005;Proceedings of the National Academy of Sciences of the United States of America;102;238-43; 15618403
  • Aggregated, wild-type prion protein causes neurological dysfunction and synaptic abnormalities.;Chiesa Roberto, Piccardo Pedro, Biasini Emiliano, Ghetti Bernardino, Harris David A, ;2008;The Journal of neuroscience : the official journal of the Society for Neuroscience;28;13258-67; 19052217
  • Mutant prion protein expression causes motor and memory deficits and abnormal sleep patterns in a transgenic mouse model.;Dossena Sara, Imeri Luca, Mangieri Michela, Garofoli Anna, Ferrari Loris, Senatore Assunta, Restelli Elena, Balducci Claudia, Fiordaliso Fabio, Salio Monica, Bianchi Susanna, Fioriti Luana, Morbin Michela, Pincherle Alessandro, Marcon Gabriella, Villani Flavio, Carli Mirjana, Tagliavini Fabrizio, Forloni Gianluigi, Chiesa Roberto, ;2008;Neuron;60;598-609; 19038218
  • Mutant PrP suppresses glutamatergic neurotransmission in cerebellar granule neurons by impairing membrane delivery of VGCC α(2)δ-1 Subunit.;Senatore Assunta, Colleoni Simona, Verderio Claudia, Restelli Elena, Morini Raffaella, Condliffe Steven B, Bertani Ilaria, Mantovani Susanna, Canovi Mara, Micotti Edoardo, Forloni Gianluigi, Dolphin Annette C, Matteoli Michela, Gobbi Marco, Chiesa Roberto, ;2012;Neuron;74;300-13; 22542184

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).